Equities

electroCore, Inc.

electroCore, Inc.

Actions
Health CareMedical Equipment and Services
  • Price (USD)6.84
  • Today's Change-0.065 / -0.94%
  • Shares traded4.18k
  • 1 Year change+22.80%
  • Beta0.6150
Data delayed at least 15 minutes, as of May 24 2024 21:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

electroCore, Inc. is a commercial stage bioelectronic medicine and wellness company. It provides non-invasive vagus nerve stimulation (nVNS) technology platform. The Company’s product categories include Handheld, personal use medical devices for the management and treatment of certain medical conditions such as primary headache, and Handheld, personal use consumer products utilizing nVNS technology to promote general wellness and human performance. Its products include gammaCore, Truvaga and TAC-STIM. Its gammaCore Sapphire, is a prescription medical device that is used for a variety of primary headache conditions. Its Truvaga is a personal use consumer electronics general wellness product that does not require a prescription and is available direct-to-consumer from electroCore at www.truvaga.com. The Company’s TAC-STIM product is not a medical device and is not intended to diagnose, cure, mitigate, prevent, or treat a disease or condition.

  • Revenue in USD (TTM)18.69m
  • Net income in USD-16.47m
  • Incorporated2005
  • Employees68.00
  • Location
    electroCore, Inc.200 FORGE WAY, SUITE 205ROCKAWAY 07866United StatesUSA
  • Phone+1 (973) 290-0097
  • Fax+1 (973) 290-9171
  • Websitehttps://www.electrocore.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Harvard Apparatus Regenertv Tchnlgy Inc160.00k-8.08m35.07m10.00--195.26--219.20-0.5824-0.58240.01150.01260.0474----16,000.00-239.52-330.30-507.69-1,524.8877.50---5,053.13-35,138.840.2558--0.7407-------44.28---39.07--
BioRegenx Inc22.24k-571.17k36.35m10.00------1,634.53-0.0021-0.00210.00008-0.00080.4899----2,224.00-1,258.22------96.85---2,568.21-----13.2366.29---47.25---629.37------
Inspira Technologies Oxy BHN Ltd0.00-11.29m37.87m37.00--5.97-----0.9549-0.95490.000.36660.00----0.00-88.60-114.98-108.36-159.56------------0.00------24.64------
Precision Optics Corporation Inc19.41m-1.64m39.81m84.00--3.53--2.05-0.2706-0.27063.241.861.064.304.51231,098.50-8.98-6.71-13.18-10.5533.6533.65-8.43-5.021.05-8.860.1982--34.2339.1284.42--19.39--
IRIDEX Corp49.92m-10.94m39.82m111.00--6.14--0.7976-0.6759-0.67593.080.39921.332.667.42449,765.80-29.16-19.54-47.74-27.4640.7242.67-21.92-15.451.03--0.00---8.964.02-26.81---24.35--
electroCore, Inc.18.69m-16.47m41.08m68.00--9.14--2.20-2.85-2.853.130.74861.161.3054.34274,897.10-102.35-70.73-177.94-88.9682.7075.81-88.12-352.821.18--0.00--86.5774.4215.02---5.88--
Cutera Inc196.64m-157.56m41.35m430.00------0.2103-7.89-7.899.86-9.600.48642.294.43457,293.00-38.97-22.00-50.24-30.7216.4247.63-80.13-27.242.22-43.941.84---15.865.47-97.76--85.87--
United Health Products Inc0.00-1.93m41.40m6.00---------0.008-0.0080.00-0.00730.000.00--0.00-719.43-6,446.86------53.19---132,561.200.0483-15.60-----100.00---55.45------
iCAD Inc17.94m-5.14m41.93m67.00--1.28--2.34-0.1982-0.08940.69151.230.40810.91992.47267,731.30-11.70-23.94-14.93-34.1485.6076.96-28.66-45.024.59--0.00---12.54-7.5329.32--23.88--
IR-Med Inc0.00-4.22m41.99m6.00---------0.0608-0.06080.00-0.00120.00----0.00-285.64---463.30--------------2.16-------3.70------
Autonomix Medical Inc0.00-10.68m43.88m3.00---------0.5055-0.50550.00-0.2649------0.00----------------------------84.50------
Vaso Corp80.54m3.18m46.69m300.0012.861.8311.420.57970.02070.02070.45890.14591.1620.037.77268,470.004.577.607.4416.6261.8358.393.955.821.37--0.0091--2.181.84-57.46---22.33--
Icecure Medical Ltd3.23m-14.65m47.10m71.00--3.87--14.59-0.3211-0.32110.07080.2660.13860.751835.6845,478.88-62.89-54.89-76.33-68.6640.2649.87-453.76-313.193.08--0.00--4.6723.5013.70--48.10--
Lucid Diagnostics Inc2.98m-54.53m47.73m70.00------16.00-1.27-1.270.06980.25440.0735--78.5042,614.29-115.88---248.82---111.06---1,576.63--1.36--0.5579--544.03--6.24------
LENSAR Inc44.50m-12.27m47.75m130.00--1.50--1.07-1.13-1.133.924.000.75361.329.79342,307.70-20.78-30.97-25.12-36.9450.4551.04-27.57-52.302.36--0.00--19.2511.5727.77---42.91--
Data as of May 24 2024. Currency figures normalised to electroCore, Inc.'s reporting currency: US Dollar USD

Institutional shareholders

16.33%Per cent of shares held by top holders
HolderShares% Held
AWM Investment Co., Inc.as of 31 Mar 2024550.36k9.17%
The Vanguard Group, Inc.as of 31 Mar 2024159.93k2.66%
Renaissance Technologies LLCas of 31 Mar 202466.52k1.11%
Geode Capital Management LLCas of 31 Mar 202452.61k0.88%
Wealthspire Advisors LLCas of 31 Mar 202447.50k0.79%
International Assets Investment Management LLCas of 31 Dec 202335.40k0.59%
Jaffe Tilchin Investment Partners LLCas of 31 Mar 202426.28k0.44%
PFG Investments LLCas of 31 Mar 202418.00k0.30%
ARS Investment Partners LLCas of 31 Mar 202412.14k0.20%
SSgA Funds Management, Inc.as of 31 Mar 202411.67k0.19%
More ▼
Data from 31 Dec 2023 - 31 Mar 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.